1Department of Sciences, Advanced Institute of Health Sciences-North, CESPU, Cooperativa de Ensino Superior, Politécnico e Universitário, CRL, Central de Gandra Street, 1317, Gandra 4585-116, Portugal.
J Anal Toxicol. 2013 Nov-Dec;37(9):670-5. doi: 10.1093/jat/bkt084. Epub 2013 Sep 30.
Tramadol is a widely used analgesic opioid for moderate-to-severe pain due to its efficacy and safety. Although tramadol induces less adverse effects compared with other opioids, an increased number of documented cases of dependence, abuse, intentional overdose or intoxication have been described. In fatal intoxication, the interpretation of the probable cause of death often relies on the measurement of the tramadol concentration in blood. However, postmortem redistribution (PMR) may affect the results and therefore bias the autopsy report. In the present study, the postmortem cardiac and femoral blood samples from 15 cases of fatal tramadol intoxication were obtained to assess the PMR of tramadol and its main active metabolite, O-desmethyltramadol (M1). Toxicological analysis was performed by the gas chromatography-electron impact-mass spectrometry (GC-EI-MS) method, previously developed and validated for the quantification of both analytes. The cardiac-to-femoral blood ratios of 1.40 and 1.28 were obtained for tramadol and M1, respectively. Results were compared with those in the literature and it was possible to conclude that femoral blood should be considered for quantitative interpretations in fatal cases of tramadol intoxication.
曲马多是一种广泛应用于中重度疼痛的阿片类镇痛药,因其疗效确切且安全性好。虽然与其他阿片类药物相比,曲马多引起的不良反应较少,但有越来越多的文献报道其具有依赖性、滥用、故意过量或中毒等问题。在致命性中毒中,判断死亡原因通常依赖于血液中曲马多浓度的检测。然而,死后再分布(PMR)可能会影响检测结果,从而导致尸检报告产生偏差。在本研究中,从 15 例致命性曲马多中毒的尸体心脏和股动脉血样中评估了曲马多及其主要活性代谢物 O-去甲基曲马多(M1)的死后再分布情况。采用气相色谱-电子轰击-质谱法(GC-EI-MS)进行毒理学分析,该方法是为定量检测这两种分析物而先前开发和验证的。曲马多和 M1 的心血比和股血比分别为 1.40 和 1.28。研究结果与文献进行了比较,结果表明在曲马多中毒的致死案例中,股动脉血应被视为定量解释的依据。